| Mrs Sandrine Y Webb, CRNA | |
|
14506 W Granite Valley Dr Ste 215, Sun City West, AZ 85375-6013 | |
| (623) 584-9985 | |
| Not Available |
| Full Name | Mrs Sandrine Y Webb |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 14506 W Granite Valley Dr Ste 215, Sun City West, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174854806 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | CRNA0650 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arlington Anesthesia Group Pllc | 2860798303 | 33 |
News Archive
Summer is all about barbeques and lazy days at the pool. It's also a good time to start thinking about preparing for flu season, and the vaccinations you or your child may need for the upcoming year, says Carrie Maffeo, a professor of pharmacy at Butler University, who specializes in immunizations.
Boston Scientific Corporation has announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System.
Cancer is a disease of evolution: cancer cells continually grow and change, and new mutations allow them to spread, even as treatments have continued to improve.
DBV Technologies, an emerging biotechnology company, announced today that it has secured $25.5 million (€19,4 million) in a Series C financing round. The round was co-led by new investors InnoBio Fund (managed by CDC Entreprises within FSI France Investment program) and Lundbeckfond Ventures.
› Verified 6 days ago
| Entity Name | Allied Anesthesia & Pain Management Consultants, L.l.p. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942327192 PECOS PAC ID: 3375506058 Enrollment ID: O20041104000828 |
News Archive
Summer is all about barbeques and lazy days at the pool. It's also a good time to start thinking about preparing for flu season, and the vaccinations you or your child may need for the upcoming year, says Carrie Maffeo, a professor of pharmacy at Butler University, who specializes in immunizations.
Boston Scientific Corporation has announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System.
Cancer is a disease of evolution: cancer cells continually grow and change, and new mutations allow them to spread, even as treatments have continued to improve.
DBV Technologies, an emerging biotechnology company, announced today that it has secured $25.5 million (€19,4 million) in a Series C financing round. The round was co-led by new investors InnoBio Fund (managed by CDC Entreprises within FSI France Investment program) and Lundbeckfond Ventures.
› Verified 6 days ago
| Entity Name | Arlington Anesthesia Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023483153 PECOS PAC ID: 2860798303 Enrollment ID: O20160310000125 |
News Archive
Summer is all about barbeques and lazy days at the pool. It's also a good time to start thinking about preparing for flu season, and the vaccinations you or your child may need for the upcoming year, says Carrie Maffeo, a professor of pharmacy at Butler University, who specializes in immunizations.
Boston Scientific Corporation has announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System.
Cancer is a disease of evolution: cancer cells continually grow and change, and new mutations allow them to spread, even as treatments have continued to improve.
DBV Technologies, an emerging biotechnology company, announced today that it has secured $25.5 million (€19,4 million) in a Series C financing round. The round was co-led by new investors InnoBio Fund (managed by CDC Entreprises within FSI France Investment program) and Lundbeckfond Ventures.
› Verified 6 days ago
| Entity Name | Zenith Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497282594 PECOS PAC ID: 9335418714 Enrollment ID: O20170628000019 |
News Archive
Summer is all about barbeques and lazy days at the pool. It's also a good time to start thinking about preparing for flu season, and the vaccinations you or your child may need for the upcoming year, says Carrie Maffeo, a professor of pharmacy at Butler University, who specializes in immunizations.
Boston Scientific Corporation has announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System.
Cancer is a disease of evolution: cancer cells continually grow and change, and new mutations allow them to spread, even as treatments have continued to improve.
DBV Technologies, an emerging biotechnology company, announced today that it has secured $25.5 million (€19,4 million) in a Series C financing round. The round was co-led by new investors InnoBio Fund (managed by CDC Entreprises within FSI France Investment program) and Lundbeckfond Ventures.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sandrine Y Webb, CRNA 19619 N 67th Dr, Glendale, AZ 85308-5562 Ph: (925) 895-4896 | Mrs Sandrine Y Webb, CRNA 14506 W Granite Valley Dr Ste 215, Sun City West, AZ 85375-6013 Ph: (623) 584-9985 |
News Archive
Summer is all about barbeques and lazy days at the pool. It's also a good time to start thinking about preparing for flu season, and the vaccinations you or your child may need for the upcoming year, says Carrie Maffeo, a professor of pharmacy at Butler University, who specializes in immunizations.
Boston Scientific Corporation has announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System.
Cancer is a disease of evolution: cancer cells continually grow and change, and new mutations allow them to spread, even as treatments have continued to improve.
DBV Technologies, an emerging biotechnology company, announced today that it has secured $25.5 million (€19,4 million) in a Series C financing round. The round was co-led by new investors InnoBio Fund (managed by CDC Entreprises within FSI France Investment program) and Lundbeckfond Ventures.
› Verified 6 days ago
Jack E Tobey, CRNA MS Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 14502 W Meeker Blvd, Sun City West, AZ 85375 Phone: 623-524-4000 | |
Mrs. Edith Ann Ast, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 20203 N Crown Ridge Dr, Sun City West, AZ 85375 Phone: 623-687-1717 Fax: 623-584-9968 | |
Joanne L Anderson, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 19052 N R H Johnson Blvd, Sun City West, AZ 85375 Phone: 623-975-2020 Fax: 623-975-7005 | |
Erik E Like, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 19424 N Rh Johnson Blvd, Sun City West, AZ 85375 Phone: 623-584-9985 Fax: 623-584-9986 |